Ricerc@Sapienza

The effects of the patented treated-yeast, Saccharomyces cerevisiae, a
probiotic suspension which was shown earlier to present
neuroprotective and neurorestorative properties, upon allergies
presented by a group (n=8) of patients, that were compared with a
matched group of patients administered untreated yeast cells (n=8).
Treated yeast cells were subjected to millimeter-wave exposure as
outlined in patented documents. The patients who administered

SARS-CoV-2 infection shows a wide-ranging clinical severity, requiring prognostic markers. We focused on S100B, a calcium-binding protein present in biological fluids, being a reliable biomarker in disorders having inflammatory processes as common basis and RAGE as main receptor. Since Covid-19 is characterized by a potent inflammatory response also involving RAGE, we tested if S100B serum levels were related to disease severity. Serum samples (n = 74) were collected from hospitalized SARS-CoV-2 positive patients admitted to Covid center.

Defining the burden of olfactory dysfunction in COVID-19 patients.